← Leaderboards
Jan E Schnitzer
Sidney Kimmel Cancer Center
$41,300,558
Attributed
$41,300,558
Total exposure
21
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $8.2M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$79,104,659 · 24
By mechanism
P01$48,850,086 · 9
R01$21,513,934 · 9
R33$4,449,264 · 2
U01$2,400,383 · 2
R24$1,887,034 · 1
P41$3,958 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Image”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$332,241,999
- Leonard Freedman · Leidos Biomedical Research, Inc.$321,574,964
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$217,904,052
- Ethan Schreier · Associated Universities, Inc.$206,468,864
Research focus
ImageTissuesBlood VesselsCaveolaeAntibodiesEndothelial CellsPharmaceutical PreparationsDrug Delivery SystemsSolid NeoplasmVascular EndotheliumProgramsProteomicsSurfaceIn VivoEndotheliumPenetrationCell SurfaceDesignDosePathway InteractionsLungMediatingCellsTreatment Efficacy
Grant awards (103)
Bispecific immunotherapeutic delivery system for lung diseases$924,314
R01 · FY2025 · HL · contact PI
Bispecific immunotherapeutic delivery system for lung diseases$905,828
R01 · FY2024 · HL · contact PI
Precision Delivery and Imaging to Enhance Solid Tumor Therapy$2,519,995
P01 · FY2023 · CA · contact PI
Bispecific immunotherapeutic delivery system for lung diseases$924,314
R01 · FY2023 · HL · contact PI
Administrative Core$353,934
P01 · FY2023 · CA · contact PI
Precision Antibody Imaging & Radiotherapy of Solid Tumors$297,031
P01 · FY2023 · CA · contact PI
Precision Delivery and Imaging to Enhance Solid Tumor Therapy$2,534,428
P01 · FY2022 · CA · contact PI
Precision Antibody Imaging & Radiotherapy of Solid Tumors$329,195
P01 · FY2022 · CA · contact PI
Administrative Core$275,681
P01 · FY2022 · CA · contact PI
Precision Delivery and Imaging to Enhance Solid Tumor Therapy$2,678,066
P01 · FY2021 · CA · contact PI
Precision Antibody Imaging & Radiotherapy of Solid Tumors$514,252
P01 · FY2021 · CA · contact PI
Administrative Core$361,157
P01 · FY2021 · CA · contact PI
Precision Delivery and Imaging to Enhance Solid Tumor Therapy$2,667,097
P01 · FY2020 · CA · contact PI
Precision Antibody Imaging & Radiotherapy of Solid Tumors$586,120
P01 · FY2020 · CA · contact PI
Administrative Core$361,157
P01 · FY2020 · CA · contact PI
Precision Delivery and Imaging to Enhance Solid Tumor Therapy$2,788,878
P01 · FY2019 · CA · contact PI
Novel Targeted Therapies for Pulmonary Fibrosis$2,697,594
P01 · FY2019 · HL · contact PI
Precision Antibody Imaging & Radiotherapy of Solid Tumors$716,609
P01 · FY2019 · CA · contact PI
Targeting Endothelial Caveolae for Lung Delivery$410,608
P01 · FY2019 · HL · contact PI
Nanodelivery to enhance the imaging and therapy of breast cancer$410,491
U01 · FY2019 · CA · contact PI
Targeting Caveolae in Breast Tumors$410,490
U01 · FY2019 · CA · contact PI
Administrative Core$361,157
P01 · FY2019 · CA · contact PI
Administrative and Biostatistical Core$361,091
P01 · FY2019 · HL · contact PI
Novel Targeted Therapies for Pulmonary Fibrosis$2,697,831
P01 · FY2018 · HL · contact PI
Nanodelivery to enhance the imaging and therapy of breast cancer$423,188
R01 · FY2018 · CA · contact PI
Targeting Caveolae in Breast Tumors$423,188
U01 · FY2018 · CA · contact PI
Targeting Endothelial Caveolae for Lung Delivery$409,811
P01 · FY2018 · HL · contact PI
Administrative and Biostatistical Core$359,285
P01 · FY2018 · HL · contact PI
Novel Targeted Therapies for Pulmonary Fibrosis$2,698,059
P01 · FY2017 · HL · contact PI
Nanodelivery to enhance the imaging and therapy of breast cancer$423,188
R01 · FY2017 · CA · contact PI
Targeting Endothelial Caveolae for Lung Delivery$410,609
P01 · FY2017 · HL · contact PI
Administrative and Biostatistical Core$361,091
P01 · FY2017 · HL · contact PI
Targeting Caveolae in Breast Tumors$309,838
U01 · FY2017 · CA · contact PI
Novel Targeted Therapies for Pulmonary Fibrosis$2,698,274
P01 · FY2016 · HL · contact PI
Targeting Caveolae in Breast Tumors$423,188
U01 · FY2016 · CA · contact PI
Nanodelivery to enhance the imaging and therapy of breast cancer$423,188
R01 · FY2016 · CA · contact PI
Targeting Endothelial Caveolae for Lung Delivery$410,608
P01 · FY2016 · HL · contact PI
Administrative and Biostatistical Core$361,091
P01 · FY2016 · HL · contact PI
Novel Targeted Therapies for Pulmonary Fibrosis$2,783,129
P01 · FY2015 · HL · contact PI
Targeting Caveolae in Breast Tumors$423,188
U01 · FY2015 · CA · contact PI
Nanodelivery to enhance the imaging and therapy of breast cancer$423,188
R01 · FY2015 · CA · contact PI
Targeting Endothelial Caveolae for Lung Delivery$410,608
P01 · FY2015 · HL · contact PI
Administrative and Biostatistical Core$382,341
P01 · FY2015 · HL · contact PI
NEOVASCULATURE TARGETING OF SPONTANEOUS SOLID TUMORS$331,184
P01 · FY2009 · CA · contact PI
IMAGING CORE$279,517
P01 · FY2009 · CA · contact PI
Mapping Vascular Proteome for Organ Targeting in Vivo$178,346
R01 · FY2009 · HL · contact PI
Targeting Vessels in Tumors$2,637,795
P01 · FY2008 · CA · contact PI
Nanotechnology Platform for Targeting Solid Tumors$763,442
R01 · FY2008 · CA · contact PI
Mapping Vascular Proteome for Organ Targeting in Vivo$742,727
R01 · FY2008 · HL · contact PI
Role and Utility of Annexins in Endothelium of Solid Tum$402,978
R01 · FY2008 · CA · contact PI
Technology/Map Endothelial Targets/Human Renal Tumors$329,945
R33 · FY2008 · CA · contact PI
NEOVASCULATURE TARGETING OF SPONTANEOUS SOLID TUMORS$323,988
P01 · FY2008 · CA · contact PI
IMAGING CORE$273,309
P01 · FY2008 · CA · contact PI
Targeting Vessels in Tumors$2,615,782
P01 · FY2007 · CA · contact PI
Nanotechnology Platform for Targeting Solid Tumors$777,850
R01 · FY2007 · CA · contact PI
Mapping Vascular Proteome for Organ Targeting in Vivo$755,456
R01 · FY2007 · HL · contact PI
Technology/Map Endothelial Targets/Human Renal Tumors$695,086
R33 · FY2007 · CA · contact PI
Role and Utility of Annexins in Endothelium of Solid Tum$402,978
R01 · FY2007 · CA · contact PI
NEOVASCULATURE TARGETING OF SPONTANEOUS SOLID TUMORS$321,443
P01 · FY2007 · CA · contact PI
IMAGING CORE$271,017
P01 · FY2007 · CA · contact PI
Targeting Vessels in Tumors$2,612,712
P01 · FY2006 · CA · contact PI
Mapping Vascular Proteome for Organ Targeting in Vivo$780,972
R01 · FY2006 · HL · contact PI
Technology/Map Endothelial Targets/Human Renal Tumors$714,748
R33 · FY2006 · CA · contact PI
Nanotechnology Platform for Targeting Solid Tumors$677,789
R01 · FY2006 · CA · contact PI
TISSUE TARGETING TO ENDOTHELIUM AND ITS CAVEOLAE$470,185
R01 · FY2006 · HL · contact PI
Targeting Caveolae in Breast Tumors$431,066
R01 · FY2006 · CA · contact PI
Role and Utility of Annexins in Endothelium of Solid Tum$415,013
R01 · FY2006 · CA · contact PI
Proteomic Resource for Basic & Clinical Cancer Research$392,594
R24 · FY2006 · CA · contact PI
NEOVASCULATURE TARGETING OF SPONTANEOUS SOLID TUMORS$204,165
P01 · FY2006 · CA · contact PI
IMAGING CORE$189,849
P01 · FY2006 · CA · contact PI
Targeting Vessels in Tumors$3,174,461
P01 · FY2005 · CA
Mapping Vascular Proteome for Organ Targeting in Vivo$796,492
R01 · FY2005 · HL
Nanotechnology Platform for Targeting Solid Tumors$619,999
R01 · FY2005 · CA
IMAGING CORE$619,427
P01 · FY2005 · CA
TISSUE TARGETING TO ENDOTHELIUM AND ITS CAVEOLAE$481,500
R01 · FY2005 · HL
Targeting Caveolae in Breast Tumors$441,440
R01 · FY2005 · CA
Role and Utility of Annexins in Endothelium of Solid Tum$425,000
R01 · FY2005 · CA
Proteomic Resource for Basic &Clinical Cancer Research$390,336
R24 · FY2005 · CA
NEOVASCULATURE TARGETING OF SPONTANEOUS SOLID TUMORS$198,650
P01 · FY2005 · CA
DIRECT PROTEOMIC MAPPING OF THE LUNG MICROVASCULAR ENDOTHELIAL CELL SURFACE IN$3,958
P41 · FY2005 · RR
Technology to Unmask Accessible Tumor Vascular Targets$789,795
R33 · FY2004 · CA
TISSUE TARGETING TO ENDOTHELIUM AND ITS CAVEOLAE$481,500
R01 · FY2004 · HL
Mechanotransduction by endothelium and its caveolae$446,400
R01 · FY2004 · HL
Targeting Caveolae in Breast Tumors$441,440
R01 · FY2004 · CA
MOLECULAR BASIS OF CAPILLARY PERMEABILITY$431,775
R01 · FY2004 · HL
Role and Utility of Annexins in Endothelium of Solid Tum$425,000
R01 · FY2004 · CA
Proteomic Resource for Basic &Clinical Cancer Research$378,964
R24 · FY2004 · CA
Technology to Unmask Accessible Tumor Vascular Targets$791,326
R33 · FY2003 · CA
TISSUE TARGETING TO ENDOTHELIUM AND ITS CAVEOLAE$481,500
R01 · FY2003 · HL
Mechanotransduction by endothelium and its caveolae$446,400
R01 · FY2003 · HL
Targeting Caveolae in Breast Tumors$441,440
R01 · FY2003 · CA
MOLECULAR BASIS OF CAPILLARY PERMEABILITY$431,775
R01 · FY2003 · HL
Proteomic Resource for Basic &Clinical Cancer Research$367,929
R24 · FY2003 · CA
Technology to Unmask Accessible Tumor Vascular Targets$1,128,364
R33 · FY2002 · CA
Mechanotransduction by endothelium and its caveolae$446,400
R01 · FY2002 · HL
Targeting Caveolae in Breast Tumors$441,440
R01 · FY2002 · CA
MOLECULAR BASIS OF CAPILLARY PERMEABILITY$431,775
R01 · FY2002 · HL
Proteomic Resource for Basic &Clinical Cancer Research$357,211
R24 · FY2002 · CA
TISSUE TARGETING TO ENDOTHELIUM AND ITS CAVEOLAE$435,195
R01 · FY2001 · HL
MOLECULAR BASIS OF CAPILLARY PERMEABILITY$431,775
R01 · FY2001 · HL
Mechanotransduction by endothelium and its caveolae$431,640
R01 · FY2001 · HL
MOLECULAR BASIS OF CAPILLARY PERMEABILITY$431,775
R01 · FY2000 · HL
TISSUE TARGETING TO ENDOTHELIUM AND ITS CAVEOLAE$426,263
R01 · FY2000 · HL